x

Search for a clinical trial

* (*) mandatory field

A Phase 1/2 Combined Dose Ranging and Randomised, Open-label, Comparative Study of the Efficacy and Safety of Plerixafor in Addition to Standard Regimens for Mobilisation of Haematopoietic Stem Cells into Peripheral Blood [...] in Paediatric Patients, Aged 2 to <18 Years, with Solid Tumours Eligible for Autologous Transplants - ES (completed)

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : European
  • Sponsor : Genzyme europe b.v.
    • Phase : I - II
  • Principal investigator of clinical trial

  • Dr Cristina DIAZ DE HEREDIA
  • Servicio de Oncología y Hematología Pediátricas
  • Hospital Universitari Vall d'Hebron
  • Paseo Vall d'Hebron, 119-129
  • 08035 BARCELONA
  • SPAIN
  • More information
  • Phone  : 34 934 89 30 93
  • Fax  : -
  • Website
  • Investigator of clinical trial

  • Dr Jaume MORA GRAUPERA
  • Servicio de Oncología y Hematología
  • Hospital Sant Joan de Déu Barcelona
  • Paseo de Sant Joan de Déu, 2
  • 08950 ESPLUGUES DE LLOBREGAT
  • SPAIN
  • More information
  • Phone  : 34 93 253 21 00
  • Fax  : -
  • Website
  • Investigator of clinical trial

  • Pr José SÁNCHEZ DE TOLEDO
  • Servicio de Oncología y Hematología Pediátricas
  • Hospital Universitari Vall d'Hebron
  • Paseo Vall d'Hebron, 119-129
  • 08035 BARCELONA
  • SPAIN
  • More information
  • Phone  : 34 934 89 30 93
  • Fax  : -
  • Website
Last update: May 2017

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.